Stem Cells for Corneal Engineering
Stem Cells for Corneal Engineering
批准号:
8450197
负责人:
JAMES L FUNDERBURGH
金额:
$42.29万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-15 至 2015-03-31
关键词:
AddressAdoptedAdultAffectAnimal ModelAnteriorArchitectureBiologicalBiomedical EngineeringBlindnessCaliberCattleCell ProliferationCell TherapyCicatrixClinical TrialsCollagenConfocal MicroscopyConnective TissueCorneaCorneal OpacityCorneal StromaDebridementDepositionDevelopmentEffectivenessEngineeringEpithelialEstersExcisionExhibitsExtracellular MatrixEyeFibroblastsFibrosisFundingGelGene ExpressionGenerationsGenetic ModelsGoalsHealthHumanImageImageryImmuneImmunologic MarkersIn VitroIndividualInjection of therapeutic agentKeratoplastyKnockout MiceLaboratoriesLamellar KeratoplastyMatrix MetalloproteinasesMedicalModelingMolecular ProfilingMusNatural regenerationOperative Surgical ProceduresOryctolagus cuniculusPhasePhenotypeProcessPropertyProteoglycanProtocols documentationReadinessSourceStem cellsTestingTherapeuticThickTimeTissue DonorsTissuesTranslationsTransplantationUreaUrethaneVisionVisual impairmentWound Healingadult stem cellbasebiodegradable polymercell motilitycell waterclinical applicationcorneal scarhuman adult stem cellhuman stem cellsin vitro Modelin vivoin vivo Modellumicanmonolayernanofibernovelpolyurethaneureaprogramsprotein expressionpublic health relevancerepairedresearch studyresponserestorationscaffoldsecond harmonictherapy developmenttissue regenerationwound
中文摘要
描述(申请人提供):角膜失明影响全世界数百万人,通常只能通过移植捐赠的组织来治疗。在世界上许多地区无法获得供体组织;在美国,越来越多的眼睛接受屈光手术,威胁着供移植的角膜供应。该项目的长期目标是通过开发基于干细胞的疗法来解决角膜失明问题。该项目已经鉴定和鉴定了成人角膜基质干细胞(CSSC),它可以在培养中扩增,同时保留采用角质细胞表型和形成丰富的基质样结缔组织的能力。当CSSC被培养在可生物降解聚合物聚(酯)氨酯尿素(PEUU)的平行排列纳米纤维支架上时,CSSC分泌的结缔组织与正常角膜基质相似。当将CSSC注射到LUMICAN基因敲除小鼠的基质中时,基质中的胶原蛋白变得更有组织,角膜透明度增加。重要的是,人CSSC在小鼠身上表现出免疫豁免,在没有免疫排斥的情况下存活了几个月。新的提案将测试直接从这些令人兴奋的发现中产生的具体假设。目的1通过检验以下预测来证明CSSC的组织再生过程:(A)CSSC首先通过对一组特定的基质金属蛋白酶的表达进行时间调节来去除现有组织;(B)在这一去除过程之后,CSSC通过沉积新的结缔组织来重建基质组织;以及(C)这种再生过程可以重建类似于导致大多数人角膜失明的瘢痕组织。目的2将CSSC与PEUU支架相结合,产生一种新型的生物工程组织,并测试以下预测:(A)CSSC单层在PEUU纳米纤维支架上可以整合并在小鼠角膜移植中作为透明基质组织;(B)CSSC可以整合到多层PEUU支架上,其厚度和强度相当于角膜基质;以及(C)多层构建物可以在功能上替代基质移植到使用深前板层角膜移植的兔角膜中。这项研究的科学影响将是对两种基于干细胞的治疗角膜疤痕的新方法的有效性的展示,表明每种方法都已准备好转化为临床试验。
英文摘要
DESCRIPTION (provided by applicant): Corneal blindness affects millions of individuals world-wide and usually can only be treated by transplantation of donated tissue. In many regions of the world donor tissue is not available; in the US, the supply of corneas for transplant is threatened by increasing numbers of eyes with refractive surgeries. The long-term goal of this project is to address corneal blindness by developing therapies based on stem cells. This project has already identified and characterized adult human corneal stromal stem cells (CSSC), which can be expanded in culture while retaining the ability to adopt a keratocyte phenotype and to elaborate abundant stroma-like connective tissue. When CSSC were cultured on a scaffolding of aligned paralel nanofibers of poly(ester urethane)urea (PEUU), a biodegradable polymer, they secreted connective tissue with aligned collagen similar to that of normal corneal stroma. When CSSC were injected into stromas of lumican knockout mice, collagen in the stroma became more organized and corneal transparency was increased. Importantly, human CSSC exhibited an immune privilege in mice, remaining viable for months without immune rejection. The new proposal will test specific hypotheses emanating directly from these exciting findings. Aim 1 documents the process of tissue regeneration by CSSC by testing the predictions that (a) CSSC first remove existing tissue by temporally regulated expression of a specific group of matrix metalloproteinases; (b) after this removal process, CSSC rebuild stromal tissue by deposition of new connective tissue; and (c) this regeneration process can remodel scar tissue similar to that causing most human corneal blindness. Aim 2 combines CSSC with PEUU scaffolding to produce a novel bioengineered tissue and tests the predictions that (a) CSSC monolayers on PEUU nanofiber scaffolding can integrate and function as transparent stromal tissue in mouse corneal transplants; (b) CSSC can be incorporated into multilayered PEUU scaffolding with the thickness and strength of a corneal stroma; and (c) the multilayered constructs can functionally replace stroma after transplantation into rabbit corneas using deep anterior lamellar keratoplasty. The scientific impact of this study will be a demonstration of effectiveness of two novel stem-cell based therapeutic approaches for corneal scarring, indicating a readiness for translation of each to clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bioengineering Cornea with Autologous Stem Cells
-
批准号:9113712
-
项目类别:
-
资助金额:$38.71万
-
财政年份:2016
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
A Pluripotent Stem Cell Reagent for Corneal Regeneration
-
批准号:8626779
-
项目类别:
-
资助金额:$19.14万
-
财政年份:2013
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
A Pluripotent Stem Cell Reagent for Corneal Regeneration
-
批准号:8776715
-
项目类别:
-
资助金额:$22.64万
-
财政年份:2013
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:7221869
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:7101389
-
项目类别:
-
资助金额:$28.28万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:9212811
-
项目类别:
-
资助金额:$38.72万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:8655870
-
项目类别:
-
资助金额:$43.63万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:8245697
-
项目类别:
-
资助金额:$44.52万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:7613878
-
项目类别:
-
资助金额:$8.23万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:7394345
-
项目类别:
-
资助金额:$30.28万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:8103366
-
项目类别:
-
资助金额:$44.52万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:7796625
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:7587273
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
CORE--MORPHOLOGY
-
批准号:6990104
-
项目类别:
-
资助金额:$6.84万
-
财政年份:2004
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Acellular Tissue Matrix for Bioprosthetic Corneas
-
批准号:6725478
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2003
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Acellular Tissue Matrix for Bioprosthetic Corneas
-
批准号:6630180
-
项目类别:
-
资助金额:$15.36万
-
财政年份:2003
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Acellular Tissue Matrix for Bioprosthetic Corneas
-
批准号:6864414
-
项目类别:
-
资助金额:$14.85万
-
财政年份:2003
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Tissue Culture and Histology Core
-
批准号:10394407
-
项目类别:
-
资助金额:$11.65万
-
财政年份:1997
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Tissue Culture and Histology Core
-
批准号:10597627
-
项目类别:
-
资助金额:$10.93万
-
财政年份:1997
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
PROTEOGLYCANS IN NORMAL AND SCARRED CORNEAS
-
批准号:2162980
-
项目类别:
-
资助金额:$13.46万
-
财政年份:1993
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
海外基金